Santen Pharmaceutical Co Ltd
TSE:4536
Santen Pharmaceutical Co Ltd
Pre-Tax Income
Santen Pharmaceutical Co Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Santen Pharmaceutical Co Ltd
TSE:4536
|
Pre-Tax Income
¥29.9B
|
CAGR 3-Years
37%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Pre-Tax Income
¥52.8B
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-10%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Pre-Tax Income
¥237.2B
|
CAGR 3-Years
47%
|
CAGR 5-Years
23%
|
CAGR 10-Years
8%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Pre-Tax Income
¥163.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-2%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Pre-Tax Income
¥444B
|
CAGR 3-Years
15%
|
CAGR 5-Years
28%
|
CAGR 10-Years
17%
|
|
Astellas Pharma Inc
TSE:4503
|
Pre-Tax Income
¥25B
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-15%
|
See Also
What is Santen Pharmaceutical Co Ltd's Pre-Tax Income?
Pre-Tax Income
29.9B
JPY
Based on the financial report for Mar 31, 2024, Santen Pharmaceutical Co Ltd's Pre-Tax Income amounts to 29.9B JPY.
What is Santen Pharmaceutical Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
0%
The average annual Pre-Tax Income growth rates for Santen Pharmaceutical Co Ltd have been 37% over the past three years , -7% over the past five years .